New research from the Indiana University Kelley School of Business explains how pharmaceutical companies were able to saturate the country with massive quantities of opioids, despite efforts by the Drug Enforcement Administration ...
Jun 24, 2024
0
0
Inhaled insulin could be a better option than injections or pumps for some patients with type 1 diabetes, a new clinical trial shows.
Jun 24, 2024
0
3
Chronic pain affects millions worldwide, and current treatments often rely on opioids, which carry risks of addiction and overdose. Non-addictive alternatives could revolutionize pain management, and new research targeting ...
Jun 21, 2024
0
57
A new research perspective titled "When does a melanoma metastasize? Implications for management" has been published in Oncotarget.
Jun 18, 2024
0
0
Older Australians with diabetes who embark on caravaning holidays need to ensure they are well prepared to manage their condition while away so as not to put undue pressure on regional pharmacists, a new Flinders University ...
Jun 12, 2024
0
1
Strong family relationships have long been associated with a better sense of well-being and connection. Now a team led by UT Southwestern Medical Center researchers has linked the quality of those relationships with how successfully ...
Jun 10, 2024
0
1
In Australia, opioid use is common, with approximately 13.3 million opioid prescriptions dispensed to provide pain relief for almost 3 million people between 2021–22. With opioids being so widely prescribed, it's not surprising ...
Jun 10, 2024
0
0
The National Institutes of Health (NIH) is investing approximately $30 million in total over fiscal years 2024 and 2025 to pilot a national primary care research network that integrates clinical research with community-based ...
Jun 6, 2024
0
0
Australians are no strangers to long, hot summers, but new Griffith University research has looked at the impact of hot weather on patients with pre-existing chronic diseases and how it increases their risk of being hospitalized.
Jun 4, 2024
0
0
Drugs like Ozempic, Wegovy and Mounjaro have been around for years, but they've recently been making headlines due to a rise in popularity as weight loss agents. They all belong to a class of drugs known as glucagon-like ...
Jun 4, 2024
0
46
